PHMMF
Price:
$86.36
Market Cap:
$1.32B
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and m...[Read more]
Industry
Biotechnology
IPO Date
2016-02-23
Stock Exchange
OTC
Ticker
PHMMF
According to Pharma Mar, S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 38.04. This represents a change of 15.47% compared to the average of 0.24 of the last 4 quarters.
The mean historical PE Ratio of Pharma Mar, S.A. over the last ten years is 67.08. The current 38.04 PE Ratio has changed 5.57% with respect to the historical average. Over the past ten years (40 quarters), PHMMF's PE Ratio was at its highest in in the December 2022 quarter at 209.56. The PE Ratio was at its lowest in in the December 2015 quarter at -125.56.
Average
67.08
Median
10.28
Minimum
-86.04
Maximum
664.68
Discovering the peaks and valleys of Pharma Mar, S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.73%
Maximum Annual PE Ratio = 664.68
Minimum Annual Increase = -129.54%
Minimum Annual PE Ratio = -86.04
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 53.57 | -91.94% |
| 2023 | 664.68 | 2.73% |
| 2022 | 23.52 | 111.93% |
| 2021 | 11.10 | 17.26% |
| 2020 | 9.46 | -111.00% |
| 2019 | -86.04 | 97.73% |
| 2018 | -43.51 | 105.20% |
| 2017 | -21.21 | -14.58% |
| 2016 | -24.82 | -129.54% |
| 2015 | 84.04 | 87.76% |
The current PE Ratio of Pharma Mar, S.A. (PHMMF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
247.26
5-year avg
152.46
10-year avg
67.08
Pharma Mar, S.A.’s PE Ratio is greater than Neuren Pharmaceuticals Limited (17.10), less than Genus plc (90.12), greater than PeptiDream Inc. (-38.96), greater than Oxford Nanopore Technologies plc (-11.51), greater than Mesoblast Limited (-26.64), greater than CStone Pharmaceuticals (-27.39), less than Green Thumb Industries Inc. (55.90), greater than Kuros Biosciences AG (-203.73), greater than Medacta Group S.A. (33.92), greater than AS ONE Corporation (20.43),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.10 | $1.55B | |
| 90.12 | $2.32B | |
| -38.96 | $1.41B | |
| -11.51 | $1.71B | |
| -26.64 | $1.73B | |
| -27.39 | $1.30B | |
| 55.90 | $1.59B | |
| -203.73 | $1.49B | |
| 33.92 | $1.67B | |
| 20.43 | $1.66B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharma Mar, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharma Mar, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pharma Mar, S.A.'s PE Ratio?
How is the PE Ratio calculated for Pharma Mar, S.A. (PHMMF)?
What is the highest PE Ratio for Pharma Mar, S.A. (PHMMF)?
What is the 3-year average PE Ratio for Pharma Mar, S.A. (PHMMF)?
What is the 5-year average PE Ratio for Pharma Mar, S.A. (PHMMF)?
How does the current PE Ratio for Pharma Mar, S.A. (PHMMF) compare to its historical average?